Liso-cel cost effective second-line treatment for common form of lymphoma

Liso-cel is a cost-effective second-line treatment for a common form of lymphoma. This treatment option offers a promising solution for patients who have not responded well to initial therapies. By using cookies, the site aims to improve user experience, analyze data, and provide targeted advertising. By agreeing to the use of cookies, users can continue to access and benefit from the site’s features. For more information on how cookies are used, users can refer to the site’s Cookie Policy and Cookie Settings.

Source link